Title(s):
Associate Professor of Medicine
Associate Professor of Pathology
Associate Professor of Pathology
Medical Director, The Johns Hopkins Hospital Special Coagulation Laboratory
Attending Physician, The Johns Hopkins Hospital Comprehensive Hemophilia Treatment Center
Medical Director, The Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Attending Physician, The Johns Hopkins Hospital Comprehensive Hemophilia Treatment Center
Medical Director, The Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Appointment Phone:
410-955-2000,410-955-3142
Primary Location:
The Johns Hopkins Hospital
Expertise:
Coagulation Disorders, General Internal Medicine, Hemophilia, Venous Thromboembolism
Education and Experience
Training
- Johns Hopkins University School of Medicine (Baltimore MD)/ (1988)
Fellowships
- The Johns Hopkins Hospital (Baltimore MD)/ Medicine Hematology (1997)
Certifications
- Medical Oncology, American Board of Internal Medicine (2005)
- Hematology, American Board of Internal Medicine (2004)
Locations
The Johns Hopkins Hospital
600 N. Wolfe Street
Hospital Main Entrance - Sheikh Zayed Tower
Baltimore, MD 21287
Appointment Phone: 410-955-2000,410-955-3142
Location Map
Department / Division
- Pathology
- Medicine
Centers/Institutes
Bio
Physician Title
Medical Director, The Johns Hopkins Hospital Special Coagulation Laboratory
Attending Physician, The Johns Hopkins Hospital Comprehensive Hemophilia Treatment Center
Medical Director, The Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Attending Physician, The Johns Hopkins Hospital Comprehensive Hemophilia Treatment Center
Medical Director, The Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Awards and Honors
1. (1983), Valedictorian, Summa cum Laude, Washington and Lee University
2. (1983-4), Fulbright Scholar at University of Ulm, West Germany, United States Department of State, Bureau of Educational and Cultural Affairs
3. (1991), Leighton R. Cluff Award for the Most Exemplary Physician, University of Florida
4. (1994), William R. Bell Prize in Hematology, Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology
5. (1995), ASCO Young Investigator Award, American Society of Oncology
6. (1996), C. Lockard Conley Award in Hematology , Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology
7. (2006), Osler Medical Housestaff Award for Outstanding Teaching by a Full-time Faculty Member
2. (1983-4), Fulbright Scholar at University of Ulm, West Germany, United States Department of State, Bureau of Educational and Cultural Affairs
3. (1991), Leighton R. Cluff Award for the Most Exemplary Physician, University of Florida
4. (1994), William R. Bell Prize in Hematology, Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology
5. (1995), ASCO Young Investigator Award, American Society of Oncology
6. (1996), C. Lockard Conley Award in Hematology , Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology
7. (2006), Osler Medical Housestaff Award for Outstanding Teaching by a Full-time Faculty Member
Expertise
- Coagulation Disorders
- General Internal Medicine
- Hemophilia
- Venous Thromboembolism
Professional Highlights
Chairman, Venous Thromboembolism Guidelines Committee, National Comprehensive Cancer Center Network
Research
Research and Publications
Selected from 72 articles and book chapters
1. Streiff, M.B. Vena Caval Filters: A Comprehensive Review. Blood 2000; 95(12): 3669-3677.
2. Streiff MB, Ness PM. Acquired factor V inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002 ;42(1): 18-26.
3. Streiff MB, Spivak JL. The diagnosis and management of polycythemia vera in the post-polycythemia vera study group era: A survey of American Society of Hematology (ASH) members practice patterns. Blood 2002; 99(4):1144-1149.
4. Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB. Outpatient therapy with low molecular weight heparin for treatment of venous thromboembolism: a systematic review of efficacy, safety and costs. Am J Med 2003 115(4):298-308.
5. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100(8):1717-1723
6. Kim HS, Patra A, Khan J, Arepally A, Streiff MB. Transhepatic Catheter-directed Thrombectomy and Thrombolysis of Acute Superior Mesenteric Venous Thrombosis. J Vasc Intervent Radiol 2005 16(12):1685-91
7. Streiff MB, Segal JB, Tamariz LJ, Jenckes MW, Bolger DT, Eng J, Krishnan JA, Bass EB. Duration of oral anticoagulation for venous thromboembolism: A systematic review of the literature. Am J Hematol 2006;81(9):684-91.
8. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive Percutaneous Mechanical Thrombectomy For Lower Extremity Deep Vein Thrombosis: Clinical And Economic Outcomes. J Vasc Intervent Radiol 2006 ;17(7):1099-1104.
9. Gerber DE, Segal JB, Salhotra A, Olivi A, Streiff MB. Venous thromboembolism occurs rarely in post-operative meningioma patients receiving combined modality prophylaxis. Cancer 2007; 109(2):300-305.
10. Segal JB, Streiff MB, Hoffman LV, Thornton K, Bass EB. Management of venous thromboembolism with low molecular weight heparin, catheter-directed thrombolysis, vena cava filters, compression stockings and oral anticoagulants: a systematic review of the evidence. Ann Intern Med 2007;146(3):211-222.
11. Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous Thromboembolism in Patients with HIV/AIDS: A Case-Control Study. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):310-4.
12. Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A Comparison of Clinical Outcomes with Retrievable and Permanent Inferior Vena Cava Filters. J Vasc Interv Radiol 2008; 19:393399.
13. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1,514 patients undergoing hematopoietic stem cell transplantation: Implications for VTE prevention. Blood 2008 Aug 1;112(3):504-10.
14. Biscup-Horn P, Streiff MB, Ulbrich T, Nesbit TW, Shermock KM. Impact of an Anticoagulation Management Service on Inpatient Clinical and Economic Outcomes. Ann Pharmacother 2008 Jun;42(6):777-82.
15.Shermock KM, Connor JT, Lavallee DC and Streiff MB. Clinical decision-making as the basis for assessing agreement between measures of the International Normalized Ratio. J Thromb Haemost 2009 Jan;7(1):87-93.
Review Articles:
1. Baglin TP, Bush J, Streiff MB. Guidelines on use of Vena Cava Filters. British Committee for Standards in Haematology. Brit J Haematol 2006 134(6):590-5.
2. Hann CL, Streiff MB. The role vena caval filters in the management of venous thromboembolism. Blood Rev 2005;19(4):179-202.
3. Gerber DE, Grossman SA, Streiff MB. Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 2006;24(8):1310-1318.
4. Kaufman JA, Kinney TB, Streiff MB, Sing RF, Proctor MC, Becker D, Cipolle M, Comerota AJ, Millward SF, Rogers FB, Sacks D, Venbrux AC. Guidelines for the use of retrievable and convertible vena cava filters: report of the society of interventional radiology consensus conference. J Vasc Interv Radiol 2006 17(3):449-459.
5. Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty P, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger M, Millenson M, Ortel TL, Salem R, Smith JL, Streiff MB. Venous thromboembolic disease: Clinical Practice Guideline in Oncology. J Natl Compr Canc Netw 2006 ;4(9): 838-69.
6. Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA. 2009 Mar 11;301(10):1063-5.
1. Streiff, M.B. Vena Caval Filters: A Comprehensive Review. Blood 2000; 95(12): 3669-3677.
2. Streiff MB, Ness PM. Acquired factor V inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002 ;42(1): 18-26.
3. Streiff MB, Spivak JL. The diagnosis and management of polycythemia vera in the post-polycythemia vera study group era: A survey of American Society of Hematology (ASH) members practice patterns. Blood 2002; 99(4):1144-1149.
4. Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB. Outpatient therapy with low molecular weight heparin for treatment of venous thromboembolism: a systematic review of efficacy, safety and costs. Am J Med 2003 115(4):298-308.
5. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100(8):1717-1723
6. Kim HS, Patra A, Khan J, Arepally A, Streiff MB. Transhepatic Catheter-directed Thrombectomy and Thrombolysis of Acute Superior Mesenteric Venous Thrombosis. J Vasc Intervent Radiol 2005 16(12):1685-91
7. Streiff MB, Segal JB, Tamariz LJ, Jenckes MW, Bolger DT, Eng J, Krishnan JA, Bass EB. Duration of oral anticoagulation for venous thromboembolism: A systematic review of the literature. Am J Hematol 2006;81(9):684-91.
8. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive Percutaneous Mechanical Thrombectomy For Lower Extremity Deep Vein Thrombosis: Clinical And Economic Outcomes. J Vasc Intervent Radiol 2006 ;17(7):1099-1104.
9. Gerber DE, Segal JB, Salhotra A, Olivi A, Streiff MB. Venous thromboembolism occurs rarely in post-operative meningioma patients receiving combined modality prophylaxis. Cancer 2007; 109(2):300-305.
10. Segal JB, Streiff MB, Hoffman LV, Thornton K, Bass EB. Management of venous thromboembolism with low molecular weight heparin, catheter-directed thrombolysis, vena cava filters, compression stockings and oral anticoagulants: a systematic review of the evidence. Ann Intern Med 2007;146(3):211-222.
11. Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous Thromboembolism in Patients with HIV/AIDS: A Case-Control Study. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):310-4.
12. Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A Comparison of Clinical Outcomes with Retrievable and Permanent Inferior Vena Cava Filters. J Vasc Interv Radiol 2008; 19:393399.
13. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1,514 patients undergoing hematopoietic stem cell transplantation: Implications for VTE prevention. Blood 2008 Aug 1;112(3):504-10.
14. Biscup-Horn P, Streiff MB, Ulbrich T, Nesbit TW, Shermock KM. Impact of an Anticoagulation Management Service on Inpatient Clinical and Economic Outcomes. Ann Pharmacother 2008 Jun;42(6):777-82.
15.Shermock KM, Connor JT, Lavallee DC and Streiff MB. Clinical decision-making as the basis for assessing agreement between measures of the International Normalized Ratio. J Thromb Haemost 2009 Jan;7(1):87-93.
Review Articles:
1. Baglin TP, Bush J, Streiff MB. Guidelines on use of Vena Cava Filters. British Committee for Standards in Haematology. Brit J Haematol 2006 134(6):590-5.
2. Hann CL, Streiff MB. The role vena caval filters in the management of venous thromboembolism. Blood Rev 2005;19(4):179-202.
3. Gerber DE, Grossman SA, Streiff MB. Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 2006;24(8):1310-1318.
4. Kaufman JA, Kinney TB, Streiff MB, Sing RF, Proctor MC, Becker D, Cipolle M, Comerota AJ, Millward SF, Rogers FB, Sacks D, Venbrux AC. Guidelines for the use of retrievable and convertible vena cava filters: report of the society of interventional radiology consensus conference. J Vasc Interv Radiol 2006 17(3):449-459.
5. Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty P, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger M, Millenson M, Ortel TL, Salem R, Smith JL, Streiff MB. Venous thromboembolic disease: Clinical Practice Guideline in Oncology. J Natl Compr Canc Netw 2006 ;4(9): 838-69.
6. Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA. 2009 Mar 11;301(10):1063-5.
Research Interests
- Prevention and Treatment of Venous Thromboembolism
More Info
Languages
- English
Memberships
Member, American College of Physicians 1992-Present
Member, American Society of Hematology 1995-Present
Member, International Society on Thrombosis and Haemostasis 1999-Present
Member, American Society of Hematology 1995-Present
Member, International Society on Thrombosis and Haemostasis 1999-Present
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts